Nektar Therapeutics grants 45,750 stock options and 2,775 RSUs to 16 new employees
NKTR•Nektar Therapeutics granted 45,750 non-qualified stock options and 2,775 restricted stock units to 16 new employees on October 20, 2026, under its 2025 Inducement Plan.
1. Employee awards
The awards are conditional on continued employment. The options have eight-year terms and vest 25% on the first grant anniversary, then monthly over the next three years; the restricted stock units vest 25% after the first anniversary, then quarterly over the next three years.
2. Plan capacity
A September 23, 2026 amendment increased the shares available under the plan by 250,000, to 500,000.
